Attralus
PrivateLast Round
Series B
Extension
Feb 6, 2024
Total Funding Raised
$197M
Company Overview
Attralus is a biotechnology company focused on developing immunotherapies and imaging diagnostic platforms for the treatment of systemic amyloid diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Imaging, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
pan-amyloid removalsystemic amyloidosisamyloidosis therapeuticsamyloidosis diagnosticsradiotracersmolecular imagingamyloid removalPET imagingfusion proteinATTR amyloidosisAL amyloidosiscardiac amyloidosisSPECT imagingbiologic therapyneurodegenerative diseaseproteinopathies
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Attralus Comps
Public and private peers based on sector, stage, and business model.
Attralus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Feb 6, 2024 | ||||
| Series B | Sep 8, 2021 | ||||
| Series A | Sep 14, 2020 |
Key People
Founding team and executive leadership
Attralus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series B |
| Janus Henderson Group | Series B |
| Alpha Wave Ventures | Series B Extension |
| Logos Capital | Series B Extension, Series B |
| Surveyor Capital | Series B Extension, Series B |
| Citadel | Series B |
| venBio | Series B, Series A |
Attralus Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Attralus's valuation, stock price, and market status.
Firmographic Details
HeadquartersSan Francisco, California
Employee Range21
Year Founded2019
Last FundingFeb 6, 2024
